Navigation Links
Insulin Administration and Nutritional Therapy Requires Standardized Coordination, Says ECRI Institute PSO
Date:11/15/2012

PLYMOUTH MEETING, Pa., Nov. 15, 2012 /PRNewswire-USNewswire/ -- Insulin has consistently been declared a high-alert medication due to the risks associated with its prescribing and dosing. When a nutrition order for a patient is modified, the patient's insulin regimen may inadvertently remain unreviewed or unchanged. ECRI Institute Patient Safety Organization (PSO) has seen both events and research requests pertaining to this issue.

(Logo: http://photos.prnewswire.com/prnh/20110112/DC29081LOGO)

"Because diabetic and non-diabetic patients receiving nutritional therapy and insulin are often managed by more than one practitioner, facilities need to implement a standardized process to ensure coordinated care," states Karen P. Zimmer, MD, MPH, FAAP, medical director, ECRI Institute PSO. "Yet when we further explored this topic, there was minimal literature that discussed best practices and among the hospitals we approached, there was no consensus on how to best go about this. The analysis of aggregated reports continues to reveal gaps that we need to address."

ECRI Institute PSO's recently released Patient Safety E-lert, "It's More Than Counting Carbs, It's Communication and Coordination: Insulin Administration and Nutritional Therapy," highlights this patient safety issue involving patients who are receiving enteral or total parenteral nutrition and insulin. The issue came to light when ECRI Institute PSO analyzed reports submitted by participating healthcare providers. As part of its mission to research the best approaches to improving patient care, ECRI Institute is sharing this special E-lert with the healthcare community.

"Reports submitted to Patient Safety Organizations can surface less-known or undetected risks, like those highlighted in this report," states Barbara Rebold, RN, MS, CPHQ, director of operations, ECRI Institute PSO. "We want to share the potential risk we are seeing in our PSO reports and recommend ways to prevent or mitigate that risk."

For questions about this topic, or for information about ECRI Institute PSO, contact ECRI Institute by telephone at (610) 825-6000, ext. 5558; by e-mail at pso@ecri.org; by fax at (610) 834-1275, or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA. To sign up for the PSO Monthly Brief, a free eNewsletter comprised of a brief article each month to help keep readers informed about Patient Safety Organizations, go to www.ecri.org/psobrief.

About ECRI Institute
For nearly 45 years, ECRI Institute's work in patient safety, adverse event reporting and analysis, and development of recommendations has improved patient care at hospitals and other providers around the world. The ECRI Institute Patient Safety Organization is a component of ECRI Institute, a nonprofit 501(c)(3) organization dedicated to improving the safety, quality, and cost-effectiveness of patient care. ECRI Institute has a long history of investigating adverse events and publishing authoritative risk reduction strategies. ECRI Institute is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute developed and implements the Pennsylvania Patient Safety Reporting System, a mandatory error and near-miss reporting program for Pennsylvania hospitals and other healthcare facilities, under contract to the Pennsylvania Patient Safety Authority, winner of the 2006 John M. Eisenberg Award. For more information, visit www.ecri.org. Find ECRI Institute on Facebook (www.facebook.com/ECRIInstitute) and Twitter (www.twitter.com/ECRI_Institute).


'/>"/>
SOURCE ECRI Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management
2. Insulin degludec and insulin degludec/insulin aspart receive positive vote for approval from FDA Advisory Committee
3. Lilly to Expand Indianapolis Insulin Manufacturing Operations
4. Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research
5. Biodel Announces Phase 2 Clinical Trial Initiation Of Ultra-Rapid-Acting Insulin Candidate BIOD-123
6. montméd, Inc. to Market FRiO Insulin Wallets in 20 countries of Middle East and North Africa
7. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
8. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
9. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
10. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
11. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):